CRSP
CRISPR Therapeutics AG
3월 13일 4:00 PM ET (한국 3/14 05:00)
$48.75
-0.12 ▼ -0.25%
🌙 3월 13일 7:51 PM ET (한국 3/14 08:51)
$48.51
-0.24 ▼ -0.49%
| Index | RUT | P/E | - | EPS (ttm) | -6.51 | Insider Own | 7.2% | Shs Outstand | 0.10B | Perf Week | -13.72% |
| Market Cap | 4.68B | Forward P/E | - | EPS next Y | 20.51% | Insider Trans | -3.37% | Shs Float | 0.09B | Perf Month | 0.89% |
| Enterprise Value | 2.90B | PEG | - | EPS next Q | -1.22 | Inst Own | 66.93% | Short Float | 24.21% | Perf Quarter | -15.35% |
| Income | -0.58B | P/S | 1333.13 | EPS this Y | 24.81% | Inst Trans | 4.61% | Short Ratio | 11.36 | Perf Half Y | -12.78% |
| Sales | 0.00B | P/B | 2.43 | EPS next 5Y | 27.44% | ROA | -25.81% | Short Interest | 21.56M | Perf YTD | -7.04% |
| Book/sh | 20.04 | P/C | 2.36 | EPS past 3/5Y | 8.21% -4.1% | ROE | -30.18% | 52W High | -37.88% ($78.48) | Perf Year | 16.1% |
| Cash/sh | 20.66 | P/FCF | - | Sales past 3/5Y | 43.09% 37.31% | ROIC | -27.56% | 52W Low | 62.28% ($30.04) | Perf 3Y | 6.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -49.45% | Gross Margin | -6534.67% | Volatility(W/M) | 5.86% 5.85% | Perf 5Y | -62.68% |
| Dividend TTM | - | EV/Sales | 826.94 | Sales Y/Y TTM | -90.59% | Oper. Margin | -16191.4% | ATR (14) | 3.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.32 | EPS Q/Q | -214.02% | Profit Margin | -16569.77% | RSI (14) | 39.36 | Recom | 1.9 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.32 | Sales Q/Q | -97.58% | SMA20 | -11.96% ($55.37) | Beta | 1.78 | Target Price | $80.21 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2000000 | SMA50 | -9.88% ($54.09) | Rel Volume | 1.04 | Prev Close | $48.87 |
| Employees | 393 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | -17.81% -81.69% | SMA200 | -12.39% ($55.64) | Avg Volume(3M) | 1.90M | Price | $48.75 |
| IPO | 2016/10/19 | Option/Short | Yes/Yes | Trades | 22679 | Volume | 1,972,820 | Change | -0.25% |
뉴스 로딩 중...